Skip to content
Search

Latest Stories

India's Covid-19 cases jump to 158,333

THE death toll due to COVID-19 rose to 4,531 and the number of cases climbed to 1,58,333 in India on Thursday (28). The country reported 6,566 cases and 194 deaths in the last 24 hours, the health ministry said.

The number of active COVID-19 cases stand at 86,110 while 67,691 people have recovered and one patient has migrated, it said.


Of the 194 deaths reported since Wednesday (27) morning, 105 were in Maharashtra, 23 in Gujarat, 15 in Delhi, 12 in Uttar Pradesh, eight in Madhya Pradesh, six each in Tamil Nadu, Telangana and West Bengal, three each in Karnataka and Rajasthan, two each in Bihar and Jammu and Kashmir and one each in Andhra Pradesh, Haryana and Kerala.

Of the total 4,531 fatalities, Maharashtra tops the tally with 1,897 deaths followed by Gujarat with 938 deaths, Madhya Pradesh with 313, Delhi with 303, West Bengal with 289, Uttar Pradesh with 182, Rajasthan  with 173,Tamil Nadu with 133, Telangana with 63 and Andhra Pradesh with 58 deaths.

The death toll reached 47 in Karnataka and 40 in Punjab. Jammu and Kashmir has reported 26 fatalities due to the disease, Haryana has 18 deaths while Bihar has registered 15. Odisha and Kerala have reported seven deaths each, Himachal Pradesh five, whilw Jharkhand, Uttarakhand, Chandigarh and Assam have recorded four deaths each so far. Meghalaya has reported one COVID-19 fatality so far, according to the ministry data.

The highest number of confirmed cases in the country are from Maharashtra at 56,948 followed by Tamil Nadu at 18,545, Delhi at 15,257, Gujarat at 15,195,, Rajasthan at 7,703, Madhya Pradesh at 7,261 and Uttar Pradesh at 6,991.

The number of COVID-19 cases has gone up to 4,192 in West Bengal, 3,171 in Andhra Pradesh and 3,061 in Bihar.   It has risen to  2,418 in Karnataka, 2,139 in Punjab, 2,098 in Telangana, 1,921 in Jammu and Kashmir and 1,593 in Odisha. Haryana has reported 1,381 coronavirus cases so far while Kerala has 1,004 cases. A total of 781 people have been infected with the virus in Assam and 448 in Jharkhand.

Uttarakhand has 469, Chhattisgarh has 369, Chandigarh has reported 279 cases, Himachal Pradesh has 273, Tripura has 230 and Goa has registered 68 cases so far.   Ladakh has reported 53 COVID-19 cases, Puducherry has 46 instances of infection, Manipur has 44, while Andaman and Nicobar Islands has registered 33 cases. Meghalaya has registered 20. Nagaland has reported four infections, Dadar and Nagar Haveli and Arunachal Pradesh have reported two cases each while Mizoram and Sikkim have reported a case each till how.

More For You

Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less
M&S launches strawberries

M&S’s latest offering taps into both tradition and innovation

The Wire

M&S launches strawberries and cream sandwich ahead of Wimbledon

Summary

  • M&S unveils limited edition strawberries and cream sandwich for £2.80
  • Inspired by Japanese 'sweet sandos', it features Red Diamond strawberries and whipped cream cheese
  • Available in stores now, found in the savoury sandwich aisle
  • Launch coincides with Wimbledon and British strawberry season
  • Wimbledon increases strawberries and cream price for first time in 15 years

New summer sandwich from M&S

Marks & Spencer has launched a limited edition M&S strawberry sandwich, combining classic British summer flavours with a Japanese twist. Priced at £2.80, the strawberries and cream sandwich is available in M&S stores now.

The dessert-style sandwich features M&S’s exclusive Red Diamond strawberries, whipped cream cheese, and sweetened bread. Despite its sweet contents, the product is found in the savoury sandwich section of M&S Food halls.

Keep ReadingShow less